Related Experiment Video
Updated: Feb 17, 2026
04:48
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
8.7K
Development of an iron-selective antioxidant probe with protective effects on neuronal function
Olimpo García-Beltrán1, Natalia P Mena2, Pabla Aguirre2
1Biomedical Neuroscience Institute (BNI), Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Plos One
|December 12, 2017
Summary
A novel compound, CT51, effectively neutralizes free radicals and manages iron levels in cells. This discovery offers potential therapeutic benefits for neurodegenerative diseases marked by oxidative stress and calcium dysregulation.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Neurodegenerative diseases like Parkinson's and Alzheimer's share common pathological hallmarks.
- These hallmarks include iron accumulation, oxidative stress, and calcium signaling dysregulation.
- Multifunctional compounds targeting these pathways are crucial for therapeutic development.
Purpose of the Study:
- To synthesize and characterize a novel compound, CT51.
- To evaluate CT51's efficacy in neutralizing free radicals and managing iron and calcium dysregulation.
- To explore CT51's therapeutic potential in neurodegenerative disease models.
Main Methods:
- Synthesis and characterization of CT51.
- In vitro and cellular assays for free radical neutralization.
- Iron binding affinity and cycling studies using cyclic voltammetry.
- Cellular uptake and distribution studies in neuroblastoma cells.
- Assessment of CT51's effect on lipid peroxidation and calcium signaling in neurons.
Main Results:
- CT51 demonstrated potent free radical neutralizing activity.
- CT51 selectively bound Fe2+ and Fe3+, inhibiting iron cycling.
- CT51 permeated cell membranes, distributing to mitochondria and cytoplasm.
- Intracellularly, CT51 bound iron reversibly and protected against lipid peroxidation.
- CT51 reduced agonist-induced calcium release in primary hippocampal neurons.
Conclusions:
- CT51 possesses multifunctional properties beneficial for cellular health.
- CT51's ability to counteract oxidative stress, iron dysregulation, and calcium signaling issues is promising.
- CT51 represents a potential therapeutic candidate for neurodegenerative diseases.
